In Episode 10 of DeviceTalks Weekly, we talk with two successful starters of medtech companies about how they’re building and maintaining their medtech portfolios during this pandemic landscape. Our guests this week are Dr. Justin Klein, managing partner of Vensana Capital, and Duke Rohlen, chair of Ajax Health. Together, Klein and Rohlen have created, backed and sold […]
Vensana Capital
Versant Ventures launches medtech fund Vensana with $225m
Versant Ventures said today that it completed the closing of the Vensana Capital fund, a venture capital and growth equity investment firm dedicated to the medtech sector with more than $200 million in committed capital. Vensana Capital intends to use its $225 million in funding to partner with medtech companies in their clinical development and […]
